Peptide Therapeutics has developed a technology for the construction of vaccines against several
viral infections caused by flaviviruses. The successful vaccine against yellow fever may help create
a ChimeriVax vaccine for hepatitis C, also a flavivirus. Replacing yellow fever genes with the corresponding
genes for the Hep C virus will hopefully create immunity to several different strains of the virus (
). Companies involved: Pasteur Merieux, Acambis/Peptide Therapeutics
